 NEW YORK, April 19, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Osmotica Pharmaceuticals plc Osmotica or the Company NASDAQ: OSMT. Such investors are advised to contact Robert S. 